Меню
Идёт набор NCT04824105

Modulating Anxious Coping

Без фазы С лечением Anxiety Disorders

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Repetitive Transcranial Magnetic Stimulation (rTMS).
Кому может быть актуально
Состояния в реестре: Anxiety Disorders. Базовые параметры: 18 лет — 65 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Modeling and Modulating Mechanisms of Escape, Avoidance, and Approach in the Anxiety Disorder Spectrum

Обзор

This is a study to find out if a device that temporarily alters brain activity (repetitive transcranial magnetic stimulation, rTMS) might be used to change how people with anxiety or related concerns cope with feared or anxiety-producing situations. The study is recruiting people who recently started treatment for anxiety or a related concern. The study involves 3 visits to the Medical University of South Carolina. At the first visit, participants do interviews and surveys asking about anxiety and related concerns, and they also do tasks where they see and react to emotional pictures while their brain activation is measured. At the next two visits, participants receive rTMS, which works by rapidly turning a focused magnetic field on and off repeatedly over the head in a way that passes directly through the hair, scalp, and skull and onto the brain and can temporarily increase brain activity under the magnetic field. After rTMS, participants do two tasks where they see and react to emotional situations while wearing sensors on their hand, arms, face, and head. Each visit in this study is expected to last between 2 - 4 hours. This is not a treatment study, but the study is being conducted with the hope that it will help improve treatment in the future.

Вмешательства

  • Устройство Repetitive Transcranial Magnetic Stimulation (rTMS)
    A repetitive Transcranial Magnetic Stimulation (rTMS) MagVenture MagPro TMS System will be used to deliver intermittent theta burst to ventromedial prefrontal cortex, and continuous theta burst to pre-supplementary motor area.

Первичные конечные точки

  • Change in Fear-Potentiated Startle Reflex [Срок оценки: Immediately Pre-Stimulation and Immediately Post-Stimulation (Approx. 30 minutes between assessments)]
  • Change in Speed to Initiate Avoidance Behavior [Срок оценки: Immediately Pre-Stimulation and Immediately Post-Stimulation (Approx. 30 minutes between assessments)]
Вторичные конечные точки (7)
  • Change in Escape/ Avoidance Electroencephalography [Срок оценки: Immediately Pre-Stimulation and Immediately Post-Stimulation (Approx. 30 minutes between assessments)]
  • Change in Approach/ Avoidance Conflict Electroencephalography [Срок оценки: Immediately Pre-Stimulation and Immediately Post-Stimulation (Approx. 30 minutes between assessments)]
  • Change in Task-Related Heart Rate Changes [Срок оценки: Immediately Pre-Stimulation and Immediately Post-Stimulation (Approx. 30 minutes between assessments)]
  • Change in Task-Related Skin Conductance Responding [Срок оценки: Immediately Pre-Stimulation and Immediately Post-Stimulation (Approx. 30 minutes between assessments)]
  • Change in Task-Related Perceived Control [Срок оценки: Immediately Pre-Stimulation and Immediately Post-Stimulation (Approx. 30 minutes between assessments)]
  • Change in Difficulty of Avoiding Task-Based Aversive Exposure [Срок оценки: Immediately Pre-Stimulation and Immediately Post-Stimulation (Approx. 30 minutes between assessments)]
  • Change in State Anxiety During Session [Срок оценки: Immediately Pre-Stimulation and Immediately Post-Stimulation (Approx. 30 minutes between assessments)]

Критерии участия

Критерии включения

  • 18 - 65 y.o.
  • Meets criteria for an anxiety disorder (Generalized Anxiety Disorder, Panic Disorder, Social Anxiety Disorder, Specific Phobia), posttraumatic stress disorder, obsessive- compulsive disorder, or current adjustment disorder with anxiety
  • Is currently seeking mental health treatment
  • Is able to read consent document and provide informed consent.
  • English is a first or primary fluent language.

Критерии исключения

  • Current alcohol or substance use disorder of more than mild severity (as defined by DSM-5 and determined using standardized self-report instruments)
  • Lifetime diagnosis of psychotic disorder or bipolar mania
  • Presence of neurological disorder that contraindicates TMS or neurophysiological recording: Seizure disorder Lifetime history of traumatic brain injury with loss of consciousness Neurodegenerative disorder (e.g., Alzheimer's Disease, Parkinson's Disease, Frontotemporal Dementia)
  • Presence of other medical disorder that would make it too uncomfortable to sit or lie still for long recording periods
  • Presence of standard contraindications for MRI or rTMS Metal in the body Currently pregnant Claustrophobia Significant sensitivity to noise Medical conditions or treatments that lower seizure threshold History of severe brain injury History of seizures/ epilepsy
  • Currently taking anticholinergic mediation, neuroleptic medication, or sedative/ hypnotic medication Note: SSRI, cholinesterase inhibitors or NMDA receptor antagonists are allowed if patient has been on a stable regimen of four weeks prior to enrollment
  • Currently taking chronic opiate medications or substances
  • Currently taking naltrexone

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Не применимо
Модель
Одна группа
Маскирование
Открытое
Основная цель
Фундаментальное исследование

Центры проведения

США · 1 центр
  • Medical University of South Carolina — Charleston

Идентификаторы

NCT: NCT04824105 · 00106843 · 1K23MH123931-01A1

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗